Fast-Acting, Inhaled Insulin Afrezza Approved by F.D.A.
The U.S. Food and Drug Administration has approved a fast-acting, inhalable insulin drug called Afrezza.
“Fast-Acting, Inhaled Insulin Afrezza Approved by F.D.A.” is categorized as “science and technology”. This video was licensed from Grab Networks. For additional video content, click the “video” tab at the top of this page.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.